#United States #New York #Healthcare AI #Kedrion Biopharma #InstaLILY

Advancing AI Innovation in Healthcare

Kedrion Biopharma, in collaboration with InstaLILY, is set to host the Rare Connections: Healthcare AI Innovation Summit on June 3, 2026, as part of NY Tech Week. This invitation-only event aims to gather leading figures from various sectors including pharmaceuticals, technology, and investment to discuss the practical applications of artificial intelligence (AI) within healthcare and its broader impact on patient care and operational efficiency.

The Structure of the Summit

The summit is designed as a half-day forum that promises engaging discussions and valuable insights. With a focus on operationalizing AI responsibly and effectively at scale, attendees will be exposed to real-world case studies that highlight successful AI implementations. The discussions will cover a range of topics from frontier research, clinical development, and commercial operations to investment strategies and the ethical considerations surrounding technology adoption in healthcare.

Speaker Lineup

A diverse lineup of distinguished speakers will share their expertise, including:

• - Paige Bailey, Google DeepMind
• - Olivia Howard, Bain Capital Private Equity
• - Matt Ridenour, Google DeepMind
• - Bob Rossilli, Kedrion Biopharma
• - Duccio Manetti, Kedrion Biopharma
• - Andrea Caricasole, Kedrion Biopharma
• - Amit Shah, InstaLILY AI
• - Sumantro Das, InstaLILY AI
• - Crissy Costa Behrens, Insight Partners
• - Nithya Sabanayagam Grande, Evident Microscopy
• - Omer Awan, Permira
• - Jason Leavy, Henry Schein

This spectrum of speakers emphasizes the summit's commitment to showcasing how AI is being used right now to enhance operational effectiveness and improve patient outcomes across the health systems.

Commitment to Patient-Centric Innovation

Bob Rossilli, Chief Commercial Officer of Kedrion, emphasized the company's dedication to patient-centric innovation by stating, “This summit reflects our ongoing commitment to patient-centric innovation and the potential for AI to strengthen how healthcare organizations operate within the communities we serve.”

Highlighting the importance of collaboration between biopharma and AI, Sumantro Das from InstaLILY remarked, “Bringing together voices from biopharma and AI enables meaningful conversations about how emerging technologies can support progress while being grounded in scientific rigor and responsibility.”

Registering for the Event

The Rare Connections Healthcare AI Innovation Summit is not just a networking event; it’s a pivotal moment in exploring how the healthcare landscape is shifting in favor of integrating AI solutions effectively. Due to limited capacity, interested participants must join the waitlist at this link.

About Kedrion Biopharma

Kedrion Biopharma specializes in the collection, fractionation, and distribution of blood plasma-derived therapies aimed at treating rare and debilitating conditions such as coagulation disorders and neurological diseases. With around 5,200 employees worldwide, their extensive network includes multiple plasma collection centers and production facilities in several countries. Their mission is to partner with the medical community to spur innovation and enhance patient care, emphasizing that every connection made has the potential to positively impact a patient’s life.

For more information about Kedrion, you can visit their website at www.kedrion.us.

About InstaLILY

InstaLILY offers autonomous AI solutions designed for the physical economy, streamlining workflows in industries such as healthcare and biopharma. By integrating proprietary technologies, InstaLILY empowers companies to enhance their operations without compromising data privacy or speed. Their initiatives focus on creating impactful outcomes for frontline workers, showcasing a future where responsible AI adoption is a cornerstone of operational success.

For more on InstaLILY, check out instalily.ai.

In conclusion, the Rare Connections Healthcare AI Innovation Summit represents a significant opportunity for stakeholders in the healthcare ecosystem to embrace change and innovate with purpose. As AI continues to play a crucial role in transforming healthcare operations, this event will serve as a catalyst for ongoing discussions on responsiveness within a fast-evolving industry.